학술논문

Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; JUN 1 2022, 28 11, p2449-p2460, 12p.
Subject
Language
English
ISSN
15573265